Consider the F-111 Aardvark. The name doesn’t exactly suggest nobility or aptitude, but it fits—thanks to the F-111’s elongated nose, which bears resemblance to the humble aardvark.

In this article, we are going to take a look at where Aardvark Therapeutics, Inc. (NASDAQ:AARD) stands against other stocks with at least $10 million in insider spending recently. Since Donald ...

While Aardvark Therapeutics is interested in serving this market, first it wants to validate its approach by treating patients whose excessive eating is rooted in a rare genetic disorder.

The F-111 Aardvark’s fuselage could lug bomb loads up to 31,000 pounds and fuel for missions up to 2,500 miles long. When the F-111 aircraft first took to the skies during the Cold War ...

Aardvark Therapeutics, Inc is a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of ...